Ratings by Scotiabank (Louise Chen)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2026 | Teva Pharma | TEVA | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 12/5/2025 | Teva Pharma | TEVA | New Coverage | Sector Outperform (N/A) |
27.83 (39.78) |
42.94% | Details | |
| 6/6/2025 | Sarepta Therapeutics | SRPT | Upgrade | Sector Outperform (Sector Perform) |
39.54 (18.43) |
-53.39% | Details | |
| 6/2/2025 | Blueprint Medicines | BPMC | Downgrade | Sector Perform (Sector Outperform) |
101.35 (129.46) |
27.74% | Details | |
| 4/2/2025 | Edgewise Therapeutics | EWTX | Downgrade | Sector Perform (Sector Outperform) |
20.13 (39.82) |
97.81% | Details | |
| 3/20/2025 | Sarepta Therapeutics | SRPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/7/2025 | Sarepta Therapeutics | SRPT | New Coverage | Sector Perform (N/A) |
105.56 (18.43) |
-82.54% | Details | |
| 3/7/2025 | Palvella Therapeutics | PVLA | New Coverage | Sector Outperform (N/A) |
23.94 (127.26) |
431.58% | Details | |
| 3/7/2025 | Inova Technology, Inc. | INVA | New Coverage | Sector Outperform (N/A) |
17.59 (21.15) |
20.24% | Details | |
| 3/7/2025 | Gain Therapeutics | GANX | New Coverage | Sector Outperform (N/A) |
1.80 (1.26) |
-30% | Details | |
| 3/7/2025 | Edgewise Therapeutics | EWTX | New Coverage | Sector Outperform (N/A) |
28.13 (39.82) |
41.56% | Details | |
| 3/7/2025 | Dyne Therapeutics | DYN | New Coverage | Sector Outperform (N/A) |
12.24 (15.88) |
29.74% | Details | |
| 3/7/2025 | Avidity Biosciences | RNA | New Coverage | Sector Outperform (N/A) |
30.35 (8.12) |
-73.25% | Details | |
| 3/7/2025 | ARS Pharmaceuticals Inc | SPRY | New Coverage | Sector Outperform (N/A) |
10.79 (4.28) |
-60.33% | Details | |
| 3/7/2025 | Ardelyx, Inc | ARDX | New Coverage | Sector Outperform (N/A) |
5.32 (3.16) |
-40.6% | Details | |
| 3/7/2025 | Aclaris Therapeutis | ACRS | New Coverage | Sector Outperform (N/A) |
1.82 (3.92) |
115.38% | Details | |
| 3/7/2025 | Zai Lab | ZLAB | New Coverage | Sector Outperform (N/A) |
35.91 (22.22) |
-38.12% | Details | |
| 3/7/2025 | Blueprint Medicines | BPMC | New Coverage | Sector Outperform (N/A) |
89.92 (129.46) |
43.97% | Details | |
| 3/7/2025 | Cogent | COGT | New Coverage | Sector Outperform (N/A) |
7.67 (31.14) |
306% | Details |
